Lasa Supergenerics Ltd.
BSE: 540702 | Sector: Health care |
NSE: LASA | ISIN Code: INE670X01014 |
BSE 00:00 | 01 Jul | 30.80 |
5.10 (19.84%) |
OPEN
26.00 |
HIGH
30.80 |
LOW
26.00 |
NSE 00:00 | 01 Jul | 30.80 |
5.10 (19.84%) |
OPEN
26.10 |
HIGH
30.80 |
LOW
26.10 |
OPEN | 26.00 |
PREVIOUS CLOSE | 25.70 |
VOLUME | 75322 |
52-Week high | 88.65 |
52-Week low | 25.40 |
P/E | 66.96 |
Mkt Cap.(Rs cr) | 125 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Lasa Supergenerics Ltd. (LASA) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 826.70 | 198,350.12 | 12,803.21 | 2,139.70 | 32,510.54 |
Divi's Lab. | 3,634.80 | 96,485.77 | 6,798.61 | 1,954.72 | 9,297.17 |
Cipla | 950.10 | 76,663.57 | 13,900.58 | 2,468.28 | 20,166.89 |
Dr Reddy's Labs | 4,384.35 | 72,973.12 | 13,349.10 | 2,186.40 | 18,266.10 |
Apollo Hospitals | 3,735.15 | 53,703.99 | 9,153.00 | 105.00 | 8,226.00 |
Torrent Pharma. | 2,915.00 | 49,327.63 | 6,450.83 | 1,137.85 | 10,618.60 |
Gland Pharma | 2,655.90 | 43,742.67 | 3,462.88 | 997.01 | 5,909.86 |
Abbott India | 19,081.95 | 40,549.14 | 4,310.02 | 690.69 | 2,844.49 |
Piramal Enterp. | 1,670.35 | 39,862.90 | 1,824.70 | 39.90 | 29,983.67 |
Biocon | 311.65 | 37,416.70 | 2,028.40 | 280.50 | 8,024.20 |
Zydus Lifesci. | 362.10 | 37,068.18 | 7,790.40 | 1,476.20 | 16,841.70 |
Alkem Lab | 3,020.25 | 36,107.09 | 7,219.68 | 1,685.08 | 9,195.63 |
Max Healthcare | 359.65 | 34,872.74 | 1,079.68 | -164.45 | 6,439.88 |
Aurobindo Pharma | 522.55 | 30,616.20 | 15,823.68 | 3,112.91 | 19,952.13 |
Lupin | 628.55 | 28,573.88 | 11,055.93 | 1,258.62 | 19,354.36 |
Glaxosmi. Pharma | 1,503.35 | 25,468.25 | 3,217.51 | 1,690.53 | 2,948.24 |
Laurus Labs | 466.25 | 25,053.94 | 4,707.04 | 750.09 | 5,178.13 |
Ipca Labs. | 912.90 | 23,160.27 | 5,139.16 | 1,140.77 | 5,028.39 |
Syngene Intl. | 561.00 | 22,520.22 | 2,601.40 | 393.80 | 4,609.20 |
Pfizer | 4,112.75 | 18,815.83 | 2,238.55 | 497.61 | 2,494.06 |
Quick Links for Lasa Supergenerics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices